Home/LDN Therapy/Blog/LDN and Long COVID: Emerging Evidence for a Lingering Problem
Long COVIDSeptember 7, 2026·6 min read

LDN and Long COVID: Emerging Evidence for a Lingering Problem

G
Gregg MacDonald, APRN
Pineapple Primary Care

Long COVID — the persistence of symptoms weeks, months, or years after a COVID-19 infection — has emerged as one of the most significant public health challenges of the post-pandemic era. Estimates suggest that 10–30% of COVID-19 survivors experience prolonged symptoms, including fatigue, brain fog, post-exertional malaise, breathlessness, and pain.

Conventional medicine has struggled to offer meaningful solutions. But in the search for treatments, LDN has emerged as one of the most promising candidates — and it makes biological sense.

Why LDN Makes Sense for Long COVID

The leading theories about Long COVID's mechanism align remarkably well with LDN's known mechanisms of action.

Neuroinflammation. Post-mortem and imaging studies have shown evidence of microglial activation and neuroinflammation in Long COVID patients — the exact target LDN is believed to address.

Immune dysregulation. Long COVID is characterized by persistent immune activation, elevated inflammatory cytokines, and in some patients, autoimmune-like features. LDN's immunomodulatory properties are directly relevant here.

Endorphin dysregulation. Fatigue and pain in Long COVID may be partly driven by dysregulation of the endogenous opioid system — which LDN helps normalize.

Mast cell activation. Many Long COVID patients show signs of mast cell activation syndrome (MCAS), which drives inflammatory symptoms throughout the body. LDN has shown promise in MCAS management.

What the Early Evidence Shows

While large randomized controlled trials are still underway, early data is encouraging:

  • A 2022 study found that LDN reduced fatigue and improved cognitive function in ME/CFS patients — a condition with significant overlap with Long COVID
  • Multiple case series and patient reports describe meaningful improvement in Long COVID fatigue, brain fog, and pain
  • The LDN Research Trust has documented hundreds of Long COVID patient experiences, with many reporting significant benefit
  • Dr. Jarred Younger's lab at University of Alabama Birmingham has ongoing research into LDN for Long COVID and ME/CFS

What to Expect

Patients starting LDN for Long COVID typically start at a low dose (1.5mg) and titrate slowly upward over several weeks. Response can take 4–12 weeks to become apparent. Some patients experience initial symptom fluctuation as the immune system recalibrates.

LDN is not a cure for Long COVID — but for many patients, it represents meaningful improvement in quality of life when other options have fallen short.

An Important Note

If you're considering LDN for Long COVID, it's important to work with a provider who understands the condition, the medication, and how to monitor your response. This is not a treatment to self-administer without medical supervision.

At Pineapple Primary Care, we stay current on the evolving Long COVID evidence base and can offer an informed, individualized consultation via telehealth throughout Florida.

Questions About LDN?

Book a free telehealth consultation with Pineapple Primary Care to discuss whether LDN is right for your situation. Available throughout Florida.

Book a Free LDN Consultation

Low Dose Naltrexone (LDN) is not FDA-approved for any indication. While naltrexone is an FDA-approved medication at standard doses for opioid and alcohol dependence, the use of naltrexone at low doses is considered off-label prescribing. This website provides educational information about LDN based on published clinical literature and patient experiences. Any discussion or consideration of LDN therapy should occur only in consultation with a qualified healthcare provider who can evaluate your individual medical history, current medications, and clinical circumstances. Pineapple Primary Care does not guarantee any specific outcome from LDN therapy and assumes no liability for decisions made based on this information. Always consult with your healthcare provider before starting, stopping, or modifying any medication.